Thyroid Dysfunction in Female Patients With Acne Vulgaris: [ Relation to Other Variables ]
Launched by ASSIUT UNIVERSITY · Jul 19, 2018
Trial Information
Current as of May 22, 2025
Unknown status
Keywords
ClinConnect Summary
Most of studies about thyroid dysfunction in acne patients focused on adult acne population especially females and searched for presence or absence of associating anti-thyroid antibodies with controversial results .
Some other studies were concerned with the impact of acne treatments as tetracycline, isotretinoin or radiotherapy on thyroid pathologies and dysfunction .
Global Acne Severity Scale (GAGS) is a simple, accurate, fast method for the determination of severity of acne, and it requires no special equipment and is relatively cost-effective. Its personal and interpersonal differenc...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patient with acne vulgaris from females only with different ages (starting from 16 years) , BMI groups.
- Exclusion Criteria:
- • Female patients with clinically diagnosed thyroid disease.
- • Female patients receiving isotretinoin or minocycline in the last 6 months
- • Female patients who were subject to radiotherapy or surgery in neck region.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, , Egypt
Patients applied
Trial Officials
Emad Taha
Study Director
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials